Introduction The neutrophil-to-lymphocyte ratio (NLR) is a score to estimate systemic inflammation and represents a potential prognostic marker in various types of solid cancers, including head and neck squamous cell carcinoma (HNSCC). This study aimed to investigate the prognostic value of the pretreatment NLR in anti-PD-1 immune checkpoint inhibition (ICI) of recurrent or metastatic HNSCC (R/M-HNSCC).
No takes yet. Share an insight, caveat, or question.
Stöth et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: